Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets

Diabetes. 2010 Sep;59(9):2198-208. doi: 10.2337/db09-1505. Epub 2010 Jun 14.

Abstract

Objective: To document the properties of the voltage-gated ion channels in human pancreatic alpha-cells and their role in glucagon release.

Research design and methods: Glucagon release was measured from intact islets. [Ca(2+)](i) was recorded in cells showing spontaneous activity at 1 mmol/l glucose. Membrane currents and potential were measured by whole-cell patch-clamping in isolated alpha-cells identified by immunocytochemistry.

Result: Glucose inhibited glucagon secretion from human islets; maximal inhibition was observed at 6 mmol/l glucose. Glucagon secretion at 1 mmol/l glucose was inhibited by insulin but not by ZnCl(2). Glucose remained inhibitory in the presence of ZnCl(2) and after blockade of type-2 somatostatin receptors. Human alpha-cells are electrically active at 1 mmol/l glucose. Inhibition of K(ATP)-channels with tolbutamide depolarized alpha-cells by 10 mV and reduced the action potential amplitude. Human alpha-cells contain heteropodatoxin-sensitive A-type K(+)-channels, stromatoxin-sensitive delayed rectifying K(+)-channels, tetrodotoxin-sensitive Na(+)-currents, and low-threshold T-type, isradipine-sensitive L-type, and omega-agatoxin-sensitive P/Q-type Ca(2+)-channels. Glucagon secretion at 1 mmol/l glucose was inhibited by 40-70% by tetrodotoxin, heteropodatoxin-2, stromatoxin, omega-agatoxin, and isradipine. The [Ca(2+)](i) oscillations depend principally on Ca(2+)-influx via L-type Ca(2+)-channels. Capacitance measurements revealed a rapid (<50 ms) component of exocytosis. Exocytosis was negligible at voltages below -20 mV and peaked at 0 mV. Blocking P/Q-type Ca(2+)-currents abolished depolarization-evoked exocytosis.

Conclusions: Human alpha-cells are electrically excitable, and blockade of any ion channel involved in action potential depolarization or repolarization results in inhibition of glucagon secretion. We propose that voltage-dependent inactivation of these channels underlies the inhibition of glucagon secretion by tolbutamide and glucose.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / physiology*
  • Cell Culture Techniques
  • Chlorides / pharmacology
  • Glucagon / adverse effects
  • Glucagon / metabolism*
  • Glucagon-Secreting Cells / cytology
  • Glucagon-Secreting Cells / drug effects
  • Glucagon-Secreting Cells / physiology*
  • Glucose / pharmacology*
  • Humans
  • Insulin / metabolism
  • Insulin Secretion
  • Ion Channel Gating / physiology*
  • Islets of Langerhans / cytology
  • Islets of Langerhans / metabolism*
  • Membrane Potentials / physiology*
  • Potassium Channels / physiology
  • Somatostatin / metabolism
  • Tetrodotoxin / pharmacology
  • Tolbutamide / pharmacology
  • Zinc Compounds / pharmacology

Substances

  • Chlorides
  • Insulin
  • Potassium Channels
  • Zinc Compounds
  • Tetrodotoxin
  • Somatostatin
  • zinc chloride
  • Glucagon
  • Tolbutamide
  • Glucose
  • Calcium